Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
- Status
- COMPLETED
- Phase
- PHASE2
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Night in Japan Home Sleep Monitoring Study
- Status
- UNKNOWN
- Phase
- N/A
A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery
- Status
- TERMINATED
- Phase
- PHASE4
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
- Status
- RECRUITING
- Phase
- N/A
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
- Status
- COMPLETED
- Phase
- PHASE2
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
- Status
- COMPLETED
- Phase
- PHASE3
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)
- Status
- COMPLETED
- Phase
- PHASE1